Abstract
Kolaviron (Kol‐v), an important component of Garcinia kola seed has a variety of biologic activities, including anti‐inflammatory properties. In this study, we investigated the possible anti‐inflammatory effect of Kol‐v against pro‐inflammatory responses induced by LPS and the associated signalling pathways in vitro. The protective effects of Kol‐v were determined by measuring gene expressions and activation of inflammatory molecules in LPS‐activated RAW macrophages. We found that Kol‐v inhibited LPS‐induced phosphorylation of p‐c‐JUN and p38 but not IκBα, NF‐κB (p65), ERK1/2, JNK, and IκBα degradation. Kol‐v also suppressed LPS‐induced IL‐18 and LPS‐down‐regulated IP‐10 gene expressions but had no effect on the LPS‐induced gene expression levels of IL‐1α, IL‐33, IL‐1β, IFNβ1‐1, and TNF‐α. Kol‐v concentrations (50 and 100 μM), blocked the phosphorylation of Akt, ERK1/2, IκBα, p38, and NF‐κB but not CREB. The protective effect on JNK phosphorylation was observed at 100 μM Kol‐v. At all concentrations of Kol‐v (10‐100 μM) tested, Kol‐v suppressed the production of IL‐6 in a concentration dependent manner but had no effect on LPS‐induced secretion of TNF‐α. Collectively, these results suggest that Kol‐v interferes with LPS signalling by reducing the activation of several inflammatory transcription factors and that its inhibitory action on IL‐6 secretion correlates with inhibition of ERK1/2, p38, Akt, p‐c‐JUN and JNK signalling pathways.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
More From: The FASEB Journal
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.